UL Solutions Inc. (ULS) compared with its closest peers (MEDP, CRL, IQV, CNDT, VRSK): P/E 29.5 vs industry 30.0. Peer set by Business Services; 10 comparable business services companies. First-party data.
Medpace, Charles River Laboratories International and IQVIA share UL Solutions's business model, clinical labs / cro services.
| Company | Market Cap | P/E |
|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $17.12B | 35.6 |
| Charles River Laboratories International, Inc. (CRL) | $14.20B | -70.0 |
| IQVIA Holdings Inc. (IQV) | $43.31B | 38.7 |
| Conduent Incorporated (CNDT) | $253.50M | -1.7 |
| Verisk Analytics, Inc. (VRSK) | $24.69B | 27.1 |
| HubSpot, Inc. (HUBS) | $12.34B | 98.7 |
| MSCI Inc. (MSCI) | $41.01B | 27.7 |
| Korn Ferry (KFY) | $4.29B | 16.2 |
| Astrana Health, Inc. (ASTH) | $2.10B | 93.2 |
| Okta, Inc. (OKTA) | $23.22B | 94.4 |
| Stock P/E | 29.5 |
| Sector P/E (Technology) | 34.1 |
| Industry P/E (Business Services) | 30.0 |
| vs Sector | -13.7% |
| vs Industry | -1.6% |
ULS overview · ULS earnings · ULS financials · ULS KPIs · ULS documents · ULS ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.